Chemomab Therapeutics (CMMB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chemomab Therapeutics Ltd. invites shareholders to a Special General Meeting on November 18, 2024, to vote on a proposal to grant restricted share units to their CEO. Shareholders as of October 10, 2024, are eligible to vote and are encouraged to participate in person or by proxy to ensure their representation. The board unanimously recommends voting for the proposal, with voting instructions provided via Broadridge Financial Solutions or respective banks or brokers.
For further insights into CMMB stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “…Supporting the Responsible Growth of our Industry…” Boeing Stock (NYSE:BA) Notches Up With Carbon Purchase
- “Secure Foundations for the Era of Frontier AI”: Microsoft Stock (NASDAQ:MSFT) Gains With New AI Plans
- Elon Musk Made $158 Billion in 2025, But Received None of It. Tesla Stock (NASDAQ:TSLA) Surges